DEA Administrator Michele Leonhart filed paperwork today announcing that the agency is seeking to increase its marijuana production quota for the year 2015 by nearly three-fold.
Federal regulations permit a farm at the University of Mississippi to cultivate set quantities of cannabis for use in federally approved clinical trials. Regulators at the DEA, the US Food and Drug Administration, PHS (Public Health Service), and the US National Institute on Drug Abuse must approve any clinical protocol seeking to study the plant’s effects in human subjects.
The agency says that the increased production is necessary because “research and product development involving cannabidiol is increasing beyond that previously anticipated.” The agency further acknowledges having received increased requests from NIDA “to provide for ongoing and anticipated research efforts involving marijuana.”
The majority of voters in Florida, Ohio, and Pennsylvania support permitting adults to possess marijuana legally, and super-majorities in all three states endorse allowing doctors to recommend cannabis therapy, according to survey data published today by Quinnipiac University.
Fifty-five percent of Florida voters say that they support allowing adults “to legally possess small amounts of marijuana for personal use.” (Forty-two percent oppose the idea.) In Ohio, voters back legalization by a margin of 52 percent to 44 percent. In Pennsylvania, 51 percent of voters favor legalizing marijuana versus 45 percent who oppose doing so.
Voters sentiment in favor of legalizing the plant’s availability for therapeutic purposes is even stronger. Pollsters reported that voters in all three states back medical marijuana legalization by margins of five to one: 84 percent to 14 percent in Florida, 84 percent to 15 percent in Ohio, and 88 percent to 10 percent in Pennsylvania.
Legislation seeking to regulate the plant’s use and retail sale is pending in both Florida and Pennsylvania, though to date, lawmakers have yet to hold hearings on either bill. Legislation to permit regulatory access to medical cannabis is also pending in both states.
Marijuana law reform legislation is presently pending in over 30 states. Is your state one of them? Visit NORML’s online ‘Take Action Center’ here to find out.
By clicking this link, you will have access to up-to-date bill status information. You can also quickly contact your elected officials and urge their support for these reforms with just one click.
Right now, nearly 20 states — including Connecticut, Florida, Illinois, Maryland, Massachusetts, Pennsylvania, Rhode Island, Texas, and Vermont — are debating measures to legalize the adult use and sale of the plant.
Click HERE to view NORML’s full list of pending state and federal legislation.
Get active; get NORML.
Please join NORML on May 20/21 in Washington, D.C. to lobby Congress for passage of cannabis law reform legislation pending before it.
You’ve probably seen by now the historically important bill to reform medical cannabis laws introduced in the U.S. Senate. There has never been a more exciting and receptive time to be a cannabis law reform activist in America with this political backdrop:
- 35 states have passed medical cannabis-related legislation (in 23 of these states patients have functional access to the medicine and legal protections)
- 17 states have decriminalized the possession of cannabis for adults
- 4 states have legalized the cultivation and sale of cannabis (Washington, D.C. has de-penalized the possession and use of cannabis for adults; allows limited home cultivation; no sales)
- Every national poll, including the oldest social survey data set, now indicate a majority of Americans no longer favor cannabis prohibition.
It’s indisputable. Cannabis law reform in America is happening in our lifetimes.
By the time the NORML Legislative Fly-In convenes in late May, as many as 20 reform bills will have been introduced for us to rally around in our lobbying efforts–and with the new Senate bill, for the first time since the late 1970s, there is good reason to lobby the Senate as hard as the House.
Also, and of great importance in placing upward political pressure on elected members of Congress and their staff, are the nearly 75 state legislative bills around the country that are now debating cannabis law reform measures–ranging from medical access to industrial hemp to decriminalization to legalization.
This year upwards of half the states’ legislatures are looking at dozens of reform bills and this clearly positively impacts Congress to see these needed socio-legal reforms bubbling up from their home states and regions.
For many in Congress, they know the political writing is on the wall for the federal prohibition on cannabis commerce to survive much longer.
Let’s help make their jobs easier by showing them the necessary public support to hasten cannabis law reforms at the federal level.
Lastly, there is a strong possibility that we’re going to add another event to the program, in conjunction with High Times…and featuring a famous TV and movie personality who has expressed strong interest in getting involved with the public discussion about cannabis law reform. TBA.
NORML members and supporters get first shot at the low early bird pricing of $50/person.
Also, there are sponsorship opportunities as well for cannabis-related businesses, services and organizations.
Below is a brief breakdown of lodging options for the Conference.
Thanks in advance and hope to see you at the height of Spring in the nation’s capital, being an active participant in an historic public advocacy effort to once and for all end cannabis prohibition.
-Allen St. Pierre
NORML / NORML Foundation
Fifty-three percent of Alaska voters approved Ballot Measure 2 on Election Day, permitting those over the age of 21 to lawfully possess up to one ounce of marijuana and/or to grow up to six marijuana plants (no more than three mature) for non-commercial purposes. Sharing or gifting personal use quantities of marijuana is also permitted under the new law; however the consumption of cannabis in public remains an offense.
Lawmakers will now begin the process of establishing licensing requirements for those who wish to commercially produce cannabis and/or engage in the plant’s retail sale. State regulators have up to nine months to enact rules to govern these commercial entities and are expected to begin granting operator permits by February 2016.
Since 1975, Alaskans have enjoyed personal privacy protections based on a state Supreme Court decision allowing for the possession and cultivation of personal use amounts of cannabis in one’s home. However, state lawmakers had never before codified these protections into law or permitted a legal market for marijuana production and sales.
Alaska is the third state – following Colorado and Washington – to legalize the personal possession of marijuana by adults and to license the plant’s retail production and sales. Oregon voters in November approved similar legislation (Measure 91), which is scheduled to go into effect later this year.